HK1216427A1 - 针对il-13的人抗体分子 - Google Patents

针对il-13的人抗体分子 Download PDF

Info

Publication number
HK1216427A1
HK1216427A1 HK16104446.4A HK16104446A HK1216427A1 HK 1216427 A1 HK1216427 A1 HK 1216427A1 HK 16104446 A HK16104446 A HK 16104446A HK 1216427 A1 HK1216427 A1 HK 1216427A1
Authority
HK
Hong Kong
Prior art keywords
seq
amino acid
acid sequence
sequence shown
specific binding
Prior art date
Application number
HK16104446.4A
Other languages
English (en)
Chinese (zh)
Inventor
David Monk Phillip
Jermutus Lutz
Raymond Minter Ralph
Patricia Shorrock Celia
Original Assignee
Medimmune Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0407315.1A external-priority patent/GB0407315D0/en
Application filed by Medimmune Limited filed Critical Medimmune Limited
Publication of HK1216427A1 publication Critical patent/HK1216427A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK16104446.4A 2003-07-15 2016-04-19 针对il-13的人抗体分子 HK1216427A1 (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US48751203P 2003-07-15 2003-07-15
US55821604P 2004-03-31 2004-03-31
GB0407315.1 2004-03-31
GBGB0407315.1A GB0407315D0 (en) 2003-07-15 2004-03-31 Human antibody molecules
US57379104P 2004-05-24 2004-05-24

Publications (1)

Publication Number Publication Date
HK1216427A1 true HK1216427A1 (zh) 2016-11-11

Family

ID=44535047

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16104446.4A HK1216427A1 (zh) 2003-07-15 2016-04-19 针对il-13的人抗体分子

Country Status (8)

Country Link
JP (3) JP5519567B2 (enrdf_load_stackoverflow)
KR (1) KR101073590B1 (enrdf_load_stackoverflow)
AU (1) AU2011200308B2 (enrdf_load_stackoverflow)
CY (1) CY1111467T1 (enrdf_load_stackoverflow)
HK (1) HK1216427A1 (enrdf_load_stackoverflow)
MX (1) MXPA06000258A (enrdf_load_stackoverflow)
NO (2) NO338853B1 (enrdf_load_stackoverflow)
RU (1) RU2009148270A (enrdf_load_stackoverflow)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201811177SA (en) * 2014-06-18 2019-01-30 Medimmune Llc Cell culture methods and media comprising n-acetylcysteine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07508179A (ja) * 1992-08-21 1995-09-14 シェリング・コーポレーション ヒトインターロイキン−１３
JP2005512522A (ja) * 2001-10-26 2005-05-12 セントカー・インコーポレーテツド Ｉｌ−１３ムテインタンパク質、抗体、組成物、方法および使用
ES2384100T3 (es) * 2001-12-03 2012-06-29 Alexion Pharmaceuticals, Inc. Método para producir anticuerpos híbridos
AU2003223497A1 (en) * 2002-04-05 2003-10-27 Centocor, Inc. Asthma-related anti-il-13 immunoglobulin derived proteins, compositions, methods and uses
EP1534323A2 (en) * 2002-08-30 2005-06-01 Glaxo Group Limited Il-14 vaccine for the treatment of asthma and atopic disorders
GB0407315D0 (en) * 2003-07-15 2004-05-05 Cambridge Antibody Tech Human antibody molecules
TWI307630B (en) * 2004-07-01 2009-03-21 Glaxo Group Ltd Immunoglobulins

Also Published As

Publication number Publication date
JP5922686B2 (ja) 2016-05-24
KR101073590B1 (ko) 2011-10-14
NO338853B1 (no) 2016-10-24
JP2016047843A (ja) 2016-04-07
AU2011200308A1 (en) 2011-02-17
NO342727B1 (no) 2018-07-30
KR20060054312A (ko) 2006-05-22
AU2011200308B2 (en) 2011-07-28
CY1111467T1 (el) 2015-08-05
HK1097853A1 (en) 2007-07-06
RU2009148270A (ru) 2011-06-27
NO20160707A1 (no) 2016-04-27
JP2011147454A (ja) 2011-08-04
JP5519567B2 (ja) 2014-06-11
JP2014101372A (ja) 2014-06-05
NO20060730L (no) 2006-04-10
MXPA06000258A (es) 2006-07-03
HK1155185A1 (en) 2012-05-11

Similar Documents

Publication Publication Date Title
US9856317B2 (en) Human antibody molecules for IL-13
MXPA06000240A (es) Dispositivo para la medicion de procesos de caudal volumetricos distribuidos en el tiempo.
HK1216427A1 (zh) 针对il-13的人抗体分子
HK1097853B (en) Human antibody molecules for il-13
HK1228920A1 (en) Neutralizing human antibody molecules for il-13
HK1228920A (en) Neutralizing human antibody molecules for il-13
HK1155185B (en) Human antibody molecules for il-13